![Gerald L. Wisler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gerald L. Wisler
Directeur/Bestuurslid bij JDRF T1D Fund
Profiel
Mr. Gerald L.
Wisler is an Investment Committee at JDRF T1D Fund.
He is on the Board of Directors at JDRF T1D Fund.
Mr. Wisler was previously employed as a Board Member by JDRF International, a President & Chief Executive Officer by Aegerion Pharmaceuticals, Inc., a Vice President-Marketing by Novartis Pharmaceuticals Corp., a VP-Managed Care Marketing & Contracting by Merck & Co., Inc., and a President, Chief Executive Officer & Director by Omthera Pharmaceuticals, Inc. He also served on the board at THERMALIN DIABETES LLC and Ampla Pharmaceuticals, Inc. He received his undergraduate degree from the University of Toledo (Ohio) and an MBA from the University of Toledo (Ohio).
Actieve functies van Gerald L. Wisler
Bedrijven | Functie | Begin |
---|---|---|
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Directeur/Bestuurslid | 01-01-2017 |
Eerdere bekende functies van Gerald L. Wisler
Bedrijven | Functie | Einde |
---|---|---|
JDRF International
![]() JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Directeur/Bestuurslid | 01-06-2019 |
Thermalin, Inc.
![]() Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH. | Directeur/Bestuurslid | 01-10-2015 |
AEGERION PHARMACEUTICALS, INC. | Algemeen Directeur | 01-01-2008 |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Verkoop & Marketing | 01-09-2004 |
MERCK & CO., INC. | Verkoop & Marketing | 01-06-2003 |
Opleiding van Gerald L. Wisler
University of Toledo (Ohio) | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MERCK & CO., INC. | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Omthera Pharmaceuticals, Inc.
![]() Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Health Technology |
Ampla Pharmaceuticals, Inc.
![]() Ampla Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ampla Pharmaceuticals, Inc. engages in the drug discovery of novel oral small molecule drugs for treatment of diabetes and metabolism disorders. It also designs and develops biopharmaceutical drugs. The company was founded by James R. Hauske and Eric Bednarski in 2006 and is headquartered in La Jolla, CA. | Health Technology |
Aegerion Pharmaceuticals, Inc.
![]() Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Thermalin, Inc.
![]() Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH. | Health Technology |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Finance |
JDRF International
![]() JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Commercial Services |